Physician profile

Gary S Ma

Cardiovascular Disease · San Diego, CA

NPI 1437503208

$16,971.12

in general payments reported to CMS, 2019-2025

15 companies · $2,941 in 2025

The $2,941 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Grant$10,000.00
Food and Beverage$2,603.01
Travel and Lodging$1,165.87
Education$83.64

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $10,321.00 2021-2025 Avvigo Guidance System
Edwards Lifesciences Corporation $4,049.97 2022-2025 Sapien 3 Ultra Resilia, Pascal, Evoque
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $552.72 2020-2024 Lifevest
Abiomed $434.97 2022-2025 Impella
Kestra Medical Technology Services, INC. $414.73 2022-2025 Assure Wcd
Shockwave Medical, INC $351.57 2024-2025 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Medical L6 Intravascular Lithotripsy (Ivl) Catheter
Abbott Laboratories $261.62 2021-2025 Amplatzer, Xience Skypoint
Astrazeneca Pharmaceuticals LP $151.21 2021-2023 Andexxa
Medtronic, INC. $114.85 2025 Symplicity G3
Kiniksa Pharmaceuticals, LTD. $98.88 2023 Arcalyst
Chiesi USA, INC. $83.64 2024 Kengreal
Reflow Medical INC $46.98 2025
Irhythm Technologies, INC. $37.53 2022
Lantheus Medical Imaging, INC. $28.00 2023 Definity
W. L. Gore & Associates, INC. $23.45 2024 Gore Cardioform Septal Occluder

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Gary S Ma

$16,971.12

in general payments reported 2019-2025

Years
2020-2025
Top company
Boston Scientific Corporation
Context
The $2,941 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/6164568/gary-s-ma

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.